Puma Biotechnology (PBYI)
NASDAQ:PBYI
Holding PBYI?
Track your performance easily

Puma Biotechnology (PBYI) Financial Statements

594 Followers

Puma Biotechnology Financial Overview

Puma Biotechnology's market cap is currently ―. The company's EPS TTM is $0.182; its P/E ratio is 16.13; Puma Biotechnology is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $0.33. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 47.08M$ 43.77M$ 72.18M$ 56.12M$ 54.57M
Gross Profit$ 36.42M$ 33.04M$ 47.85M$ 42.83M$ 42.71M
EBIT$ -4.15M$ -1.24M$ 16.16M$ 9.35M$ 5.64M
EBITDA$ -1.24M$ 1.66M$ 19.05M-$ 0.00
Net Income Common Stockholders$ -4.53M$ -4.82M$ 12.27M$ 5.80M$ 2.13M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 96.83M$ 107.16M$ 95.94M$ 85.03M$ 74.44M
Total Assets$ 205.00M$ 214.15M$ 230.53M$ 203.60M$ 200.49M
Total Debt$ 98.59M$ 110.73M$ 111.49M$ 112.22M$ 112.94M
Net Debt$ 1.75M$ 3.57M$ 15.55M$ 27.19M$ 38.50M
Total Liabilities$ 156.49M$ 163.17M$ 177.09M$ 164.86M$ 170.09M
Stockholders Equity$ 48.51M$ 50.98M$ 53.44M$ 38.74M$ 30.40M
Cash Flow-
Free Cash Flow$ 1.01M$ 11.25M$ 10.41M--
Operating Cash Flow$ 1.03M$ 11.25M$ 10.46M$ 10.62M-
Investing Cash Flow$ 703.00K$ -19.08M$ -8.17M$ 11.18M-
Financing Cash Flow$ -11.33M----
Currency in USD

Puma Biotechnology Earnings and Revenue History

Puma Biotechnology Debt to Assets

Puma Biotechnology Cash Flow

Puma Biotechnology Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis